BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4
283 results:

  • 1. Somatic Mutations in Surgically Treated Colorectal liver Metastases: An Overview.
    Wang J; Botvinov J; Bhatt AJ; Beyer K; Kreis ME; Adam M; Alseidi A; Margonis GA
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667294
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
    Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting smad4.
    Li Z; Ma Z; Wang S; Yan Q; Zhuang H; Zhou Z; Liu C; Chen Y; Han M; Wu Z; Huang S; Zhou Q; Hou B; Zhang C
    Biol Direct; 2024 Mar; 19(1):24. PubMed ID: 38504385
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines.
    Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z
    Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study.
    Huang L; Lv Y; Guan S; Yan H; Han L; Wang Z; Han Q; Dai G; Shi Y
    J Transl Med; 2024 Feb; 22(1):184. PubMed ID: 38378604
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. TIF1γ and smad4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
    Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
    Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies.
    Chi Y; Yuan H; Fan Q; Wang Z; Niu Z; Yu J; Yuan D
    Gene; 2024 Mar; 899():148134. PubMed ID: 38185290
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal liver Metastases.
    Boyev A; Tzeng CD; Maki H; Arvide EM; Mrema DE; Jain AJ; Haddad A; Lendoire M; Malik N; Odisio BC; Chun YS; Tran Cao HS; Vauthey JN; Newhook TE
    Ann Surg Oncol; 2024 Apr; 31(4):2547-2556. PubMed ID: 38148351
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
    Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
    Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An NFATc1/SMAD3/cJUN Complex Restricted to smad4-Deficient Pancreatic cancer Guides Rational Therapies.
    Hasselluhn MC; Schlösser D; Versemann L; Schmidt GE; Ulisse M; Oschwald J; Zhang Z; Hamdan F; Xiao H; Kopp W; Spitalieri J; Kellner C; Schneider C; Reutlinger K; Nagarajan S; Steuber B; Sastra SA; Palermo CF; Appelhans J; Bohnenberger H; Todorovic J; Kostyuchek I; Ströbel P; Bockelmann A; König A; Ammer-Herrmenau C; Schmidleitner L; Kaulfuß S; Wollnik B; Hahn SA; Neesse A; Singh SK; Bastians H; Reichert M; Sax U; Olive KP; Johnsen SA; Schneider G; Ellenrieder V; Hessmann E
    Gastroenterology; 2024 Feb; 166(2):298-312.e14. PubMed ID: 37913894
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Chanling Gao suppresses colorectal cancer via PI3K/Akt/mTOR pathway modulation and enhances quality of survival.
    Chen G; Tian TT; Wang FQ; Pan CS; Sun K; Wang XY; Yang B; Yang Z; Tang DX; Han JY
    Environ Toxicol; 2024 Mar; 39(3):1107-1118. PubMed ID: 37823609
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. TP53 Alteration and Its Effect on Pathologic Response Are Associated with Survival after Resection of Colorectal liver Metastases.
    Maki H; Haddad A; Ayabe RI; Lendoire M; Khanduri I; Maru DM; Vauthey JN
    J Gastrointest Surg; 2023 Nov; 27(11):2597-2600. PubMed ID: 37553514
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis.
    Behari J; Gougol A; Wang R; Luu HN; Paragomi P; Yu YC; Molinari M; Chopra K; Malik SM; Geller D; Yuan JM
    Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37395730
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical Utility of Bland Embolization Using Microspheres for Painful Malignant Musculoskeletal Tumors.
    Taniguchi J; Takaki H; Kodama H; Kawaguchi T; Takahagi M; Ogasawara A; Kako Y; Kobayashi K; Minami T; Futani H; Yamakado K
    In Vivo; 2023; 37(4):1816-1821. PubMed ID: 37369519
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and smad4 expression.
    Masugi Y; Takamatsu M; Tanaka M; Hara K; Inoue Y; Hamada T; Suzuki T; Arita J; Hirose Y; Kawaguchi Y; Nakai Y; Oba A; Sasahira N; Shimane G; Takeda T; Tateishi K; Uemura S; Fujishiro M; Hasegawa K; Kitago M; Takahashi Y; Ushiku T; Takeuchi K; Sakamoto M;
    J Pathol Clin Res; 2023 Sep; 9(5):339-353. PubMed ID: 37291757
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tea domain transcription factor TEAD4 mitigates TGF-β signaling and hepatocellular carcinoma progression independently of YAP.
    Luo W; Li Y; Zeng Y; Li Y; Cheng M; Zhang C; Li F; Wu Y; Huang C; Yang X; Kremerskothen J; Zhang J; Zhang C; Tu S; Li Z; Luo Z; Lin Z; Yan X
    J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36806855
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ancillary tests for hepatobiliary neoplasms: what we know and what we need to know.
    Zhang SL; Wang HL
    Hum Pathol; 2023 Nov; 141():183-200. PubMed ID: 36775105
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis.
    You H; Zhang N; Yu T; Ma L; Li Q; Wang X; Yuan D; Kong D; Liu X; Hu W; Liu D; Kong F; Zheng K; Tang R
    Br J Cancer; 2023 Apr; 128(6):992-1004. PubMed ID: 36635499
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Adult Pancreatoblastoma: Report of 3 new Cases With Genetic Diversity and Autopsy Findings.
    Machado I; López-Guerrero JA; Fernandez A; López R; García Casado Z; Ferrandez A; Llombart-Bosch A; Charville GW
    Int J Surg Pathol; 2023 Aug; 31(5):896-906. PubMed ID: 36573045
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology.
    Capuozzo M; Santorsola M; Landi L; Granata V; Perri F; Celotto V; Gualillo O; Nasti G; Ottaiano A
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499450
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.